In a groundbreaking study that could change the way we understand and approach Parkinson’s disease, researchers are delving into the mysterious link between violent dreams and the onset of this ...
We think UCB is in good financial health, with solid earnings and cash flow generation. UCB has deleveraged over the years, and it ended 2023 with about EUR 2.2 billion in net debt on its balance ...
Mapi is actively seeking new partnership opportunities for its proprietary Depot products. Company management will be available for one-on-one meetings during the HealthCONx Conference to discuss ...
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of Alzheimer's disease, ...
According to the new study, patients with a slow progression ... A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a ...